Document:

Exhibit
10.12

 

EMPLOYEE’S
NON-DISCLOSURE,

NON-SOLICITATION,
AND NON-COMPETITION AGREEMENT

 

This Non-Disclosure,
Non-Solicitation, and Non-Competition Agreement (the “Agreement”) is entered
into this          day of                  ,
20   , by and between                                             
(the “Employee”) and Safety-Kleen Systems, Inc., on behalf of itself, its
affiliates and subsidiaries, and its and their respective successors, and
assigns (Safety-Kleen Systems, Inc., its affiliates and subsidiaries, and
its and their respective successors and assigns are hereinafter collectively
referred to as the “Company”).

 

WHEREAS, the Company is
in the business of providing waste management and related services and Employee
is a member of the executive staff of the Company.  In consideration of Employee’s continued
employment, participation in the management incentive plan, access to
confidential information, and other good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged, Employee covenants
and agrees with the Company as follows:

 

1.     Covenant Not to Disclose Trade Secrets and Confidential Information.  Employee
acknowledges that the Company has information which is confidential and
information which constitutes trade secrets which the Company uses in its
business and which is essential to its continued ability to compete and be
successful in the waste management industry.

 

a.  Employee agrees that
the term “Trade Secret(s),” as used herein, shall be defined as broadly as the
applicable law allows. Employee
acknowledges that the Company’s business software and reports generated from
that software, list of suppliers and customers of the Company, the manner in
which the Company bundles services for a competitive price to customers, the
Company’s information on its customers, such as a customer’s purchases, needs,
contact information, buying history, and price paid, and the Company’s
policies, know-how and operating procedures, as the same may exist from time to
time, are valuable, special and unique assets of the Company’s business and are
Trade Secrets belonging to the Company.  The
term “Confidential Information,” as such term is used herein, shall mean any
information which the Company uses in its business and which the Company
considers to be confidential or proprietary, whether or not such information
rises to the level of a Trade Secret.

 

b.  Employee covenants and agrees
that during Employee’s employment and at all times thereafter, Employee shall
not use or disclose any Confidential Information or Trade Secrets of the
Company, for any reason or purpose whatsoever, for so long as such information
remains the Confidential Information or Trade Secrets of the Company, except as
an employee of the Company and with the prior consent of the Company.

 

2.     Covenant Not to Solicit Customers. 
Employee covenants and agrees that in the event Employee’s
employment relationship with the Company is terminated, either by Employee or
the Company, for any reason whatsoever, Employee shall not, for a period of one
(1) year following the termination of Employee’s employment with the
Company, directly or indirectly, alone or in association with or on behalf of
any other person or entity, (i) solicit for the purpose of providing waste
management and/or related services or products in competition with the Company
or (ii) perform any service in competition with the Company for, any
person or entity who is or was a customer of the Company.

 

3.     Covenant Not to Compete.
Whereas Employee is a member of the Executive staff of Employer and has access
to not only Employer’s Trade Secrets and Confidential Information, but also technical
information (including, but not limited to, processes, know-how, methods, data,
plans, specifications, formulas, inventions, electronics, computer programs,
computer codes, computer passwords, research and development projects, and
machines); business strategies; financial results; pricing data; customer lists
and data; the contents of the past, current, or future customer accounts and
customer purchasing patterns; key persons to contact with regard to customer
accounts and customer needs; market surveys and research data; contractual
agreements between Safety-Kleen and other persons or entities; compilations of
information and records that are owned by Safety-Kleen and are regularly used
in the operation of Safety-Kleen’s business;
potential liabilities and exposures; and other information that is kept
confidential by Safety-Kleen; Employee
covenants and agrees that during Employee’s employment and for a period of one (1) year
after the date of termination of such employment, whether by the Company or
Employee, for any reason whatsoever, Employee shall not, directly or
indirectly, on Employee’s own behalf or through any person or entity, in any
manner whatsoever, whether as an employee, consultant, agent, representative,
shareholder, director, officer, joint venturer, partner, sole proprietor,
investor or in any other

 

Corp Form A

 

 

ownership or financial capacity whatsoever, engage in any business or
perform any service which is competitive with or substantially similar to the
business of the Company within any state or province in which Employer was
doing business during the course of Employee’s employment by Employer.  Nothing in the foregoing shall prohibit
Employee at any time during or after Employee’s employment by the Company from
investing in the securities of any corporation having securities listed on the
national security exchange, provided that such investment does not exceed five
percent (5%) of any class of securities of any corporation engaged in business
in competition with the Company, and provided that such ownership represents a
passive investment and that neither Employee nor any group of persons including
Employee, in any way, either directly or indirectly, manages or exercises
control over any such corporation, guarantees any of its financial obligations
or otherwise takes part in its business, except in the exercise of Employee’s
rights as a shareholder.

 

4.     Covenant Not to Solicit Employees.  Employee
agrees that during the time period set forth in Paragraph 2, Employee shall
not, directly or indirectly, solicit any employee of the Company or attempt to
persuade any employee to leave the Company and work with a competitor of the
Company.

 

5.     Independent Covenants; Severability and Substitution of Valid
Provisions.    The covenants on the part of
Employee contained in paragraphs 1, 2, 3, and 4 hereof shall each be construed
as agreements independent of each other and of any other provision in this
Agreement and the unenforceability of one shall not effect the remaining
covenants. To the extent that any provision or language of this Agreement is
deemed unenforceable, by virtue of the scope of the business activity
prohibited, the geographical restriction of the prohibition or the length of
time the activity is prohibited or otherwise, the Company and Employee agree
that this Agreement shall be enforced to the fullest extent permissible under
the law.

 

6.     Remedies for Breach.  Employee recognizes and agrees that a breach
by Employee of any covenant contained in this Agreement would cause
immeasurable and irreparable harm to the Company.  In the event of a breach or threatened breach
of any covenant contained herein, the Company shall be entitled to temporary
and permanent injunctive relief, restraining Employee from violating or
threatening to violate any covenant contained herein, as well as all costs and
fees incurred by the Company, including attorneys fees, as a result of Employee’s
breach or threatened breach of the covenant. 
The Company and Employee agree that the relief described herein is in
addition to such other and further relief as may be available to the Company at
equity or by law.  Nothing herein shall
be construed as prohibiting the Company from pursuing any other remedies
available to it for such breach or threatened breach, including the recovery of
damages from Employee.

 

7.     Extension of Periods.  Each of the time periods described in this
Agreement shall be automatically extended by any length of time during which
Employee is in breach of the corresponding covenant contained herein.  The provisions of this Agreement shall
continue in full force and effect throughout the duration of the extended periods.

 

8.     Reasonableness of Covenant.  
Employee acknowledges and agrees that due to Employee’s position with
the company and Employee’s access to Confidential Information and Trade
Secrets, the covenants contained herein are each necessary for the legitimate
interests of the Company and contain reasonable limitations on Employee’s
ability to compete with the Company following Employee’s employment with the
Company.  Employee further acknowledges
that such covenants are reasonable in geographic scope, time and the overall
limitations on Employee’s activities and that valid and sufficient
consideration was given to Employee for the covenants.

 

9.     Miscellaneous.  No amendments or variation of the terms or
conditions of this Agreement shall be valid unless agreed to in writing and
signed by the parties.  This Agreement
shall bind and inure to the benefit of the Company, its successors and assigns,
and Employee and his or her heirs and legal representatives.  Employee’s rights and obligations under this
Agreement are personal and not assignable. No waiver of a breach of any
provision of this Agreement shall be construed to be a waiver of any breach of
any other provision.  No delay with
regard to enforcement of any breach of any provision of this Agreement shall be
construed to be a waiver of such breach. 
It is agreed by the parties that the
foregoing covenants in this Agreement are necessary for the legitimate business
interests of the Company and impose a reasonable restraint on Employee in light
of the activities and business of the Company on the date of the execution of
this Agreement.

 

 

10.     At-Will
Employment.  Employee
understands and agrees that Employee’s employment is “at will” and can be
terminated by the Company at any time for any reason, with or without cause or
notice.

 

 

IN WITNESS WHEREOF, the
parties hereto set their hands and seals the day and year first written above.

 

	
   

  	
   

  	
  EMPLOYEE

  
	
  Date:

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  Signature

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
  Printed Name

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
  SAFETY-KLEEN SYSTEMS,
  INC.,

  
	
   

  	
   

  	
  on behalf of itself,
  its affiliates and subsidiaries and its and their respective successors and
  assigns

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
  By:

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
  Date:

  	
   

  	
   

  	
  Its:Exhibit 10.13

 

* Confidential Treatment Requested by Celera Corporation*

 

AGREEMENT

BETWEEN

THE REGENTS OF THE UNIVERSITY OF CALIFORNIA

AS MANAGEMENT AND OPERATION CONTRACTOR OF

THE LAWRENCE BERKELEY LABORATORY

AND

BERKELEY HEARTLAB,

A CALIFORNIA CORPORATION

 

I.              INTRODUCTION

 

The regents of the University of California
(University) and the United States Government (Government) represented by the
United States Department of Energy (DOE) have entered into Contract No.
DE-AC03-76SF00098 which provides that the University will undertake certain
research and development work for the Government in the field of energy at the
Government owned Lawrence Berkeley Laboratory (LBL).  This agreement is entered into by and between
The Regents of the University of California (University) as Management and
Operations Contractor for the Lawrence Berkeley Laboratory and Berkeley
HeartLab, a California Corporation, (Hereinafter “Requester”) in order that the
work described in the attached Statement of Work be performed.  DOE has authorized the University to execute
this Agreement for work at LBL.

 

II.            TERM AND TERMINATION

 

The term of this agreement shall began when this
agreement is executed by both parties and shall continue for five years with a
minimum of 12 months.  Services under
this agreement may be terminated after 12 months, at any time by either party
by providing 30-day written notice to the other party.  In the event the agreement is terminated by
the University, the Requester shall bear the cost of services incurred by the
University prior to the effective date of termination unless such charges have
been waived.

 

III.           COST

 

Except to the extent churches have been waived by
DOE, the Requester shall pay DOE in advance for work performed hereunder on the
basis of DOE’s full cost recovery policy in effect as of the date of this
agreement.  Neither the Government, DOE,
nor the University, nor persons acting on their behalf guarantee the
correctness of any estimate of costs for the performance of work and there
shall be no liability to the Government, DOE, the University, or persons acting
on their behalf by reasons of errors in the computation of estimates or
differences between such estimates and the actual cost of the work.  Billing, if any, will be made monthly by the
University in accordance with LBL’s established billing procedures.  Payday shall be made within 30 days after
receipt of invoice. The 

 

non-waiver 1/95

 

1

 

* Confidential Treatment Requested by Celera Corporation*

 

estimated cost of the work contemplated here is
$[***].  A partial advance payment in the
amount of $[***] will be paid by Requester upon final execution of this
Agreement.

 

IV.           SCOPE OF WORK - COORDINATION
AND ADMINISTRATION

 

Except as otherwise advised by DOE, technical
contact will be between representatives of the Requester and of the University
who will agree in writing upon the specific services to be provided to the
Requester.

 

By entering into this agreement, the Requester
certifies that these services cannot be procured reasonably and expeditiously
by it through ordinary business channels.

 

	
  NOTE::

  	
   

  	
  The University, the Sponsor and the Government
  agree that the mutual obligations of the Parties created by Clauses V, VI,
  VII, VIII constitute a contract between the Sponsor and the U.S. Government,
  as represented by the Dept. of Energy, with respect to the intellectual
  property matters covered by those Clauses.

  

 

V.            PATENT RIGHTS

 

                  A.          Definitions

 

(1)                                  “Requester” means the person or entity with
which this agreement is  made.

 

(2)                                  “Subject Invention” means any invention or
discovery of the University or, to the extent the Requester is performing any
work under this agreement, of the Requester, conceived in the course of or
under this agreement, or, in the case of an invention previously conceived by
the Requester, first actually reduced to practice in the course of or under
this agreement.  “Subject Invention”
includes any art, method, process, machine, manufacture, design or composition
of matter, or any new and useful improvement thereof, or any variety of plants,
whether patented or unpatented under the Patent Laws of the United States of
America or any foreign country.

 

(3)                                  The University means the operating contractor
which manages and operates the Lawrence Berkeley Laboratory (LBL), the
Government-owned, contractor-operated facility where work under this agreement
is to be performed.

 

(4)                                  “Patent Counsel” means the DOE Patent Counsel
assisting the procuring activity which has the administrative responsibility
for the facility where work under this agreement is to be performed.

 

                  B.          Invention Disclosures and Reports

 

(1)                                  The Requester shall furnish the Patent
Counsel (with notification by Patent Counsel to the Contracting Officer) a
written report containing full and 

 

non-waiver 1/95

 

2

 

*
Confidential Treatment Requested by Celera Corporation*

 

complete
technical information concerning each Subject Invention within 6 months after
conception or first actual reduction to practice whichever occurs first in the
course of or under this agreement, but in any event prior to any sale, public
use, or public disclosure of such invention known to the Requester.  The report shall identify the agreement and
inventor and shall be sufficiently complete in technical detail and
appropriately illustrated by sketch or diagram to convey to one skilled in the
art to which the invention pertains a clear understanding of the nature,
purpose, operation, and to the extent known, the physical, chemical,
biological, or electrical characteristics of the invention;

 

(2)                                  The University shall report Subject
Inventions it makes in accordance with the procedures set forth in contract
DE-AC03-76SF00098.  In addition, the
University shall disclose to the Requester at the same time as disclosure to
DOE any Subject Inventions made by the University under this agreement and the
Requester shall notify DOE within 6 months of receipt of such disclosure by the
Requester of any election of patent rights under this clause.

 

(3)                                 Both the Requester and the University shall
submit a final report on a DOE-approved form within 3 months after completion
of the agreement listing all Subject Inventions that have been disclosed or
stating that there were no such inventions.

 

(4)                                  The Requester and the University agree that
the Government may duplicate and disclose Subject Invention disclosures and all
other reports and papers furnished or required to be furnished pursuant to this
Agreement.

 

               C.             Allocation of Principal Rights

 

(1)                                  Assignment to the Government.  The Requester agrees to assign to the
Government its entire right, title, and interest throughout the world, in and
to each Subject Invention, except to the extent that rights are retained by the
Requester under paragraphs (C)(2) and (D) of this clause.

 

(2)                                  Greater rights Determination.  The Requester or the employee-inventor with
authorization of the Requester may request greater rights than the nonexclusive
license and the right to request foreign patent rights provided in
paragraph (D) of this clause on identified inventions in accordance
with the procedures and criteria of 41 CFR 9-9.109-6.  A request for a determination of whether the
Requester or the employee-inventor is entitled to retain such greater rights
must be submitted to the Patent Counsel (with notification by Patent Counsel to
the Contracting Officer) at the time of the first disclosure of the invention
pursuant to paragraph (B) (1) or (B) (2) of this
clause or not later than 9 months after conception or first actual reduction to
practice, whichever occurs first, or such longer 

 

non-waiver 1/95

 

3

 

* Confidential
Treatment Requested by Celera Corporation*

 

period
as may be authorized by Patent Counsel (with notification by Patent to the
Contracting Officer) for good cause shown in writing by the Requester.  The information to be submitted for a greater
rights determination is specified in 41 CFR9-9.109-6(e).

 

(a)                                  Preference for U. S. Industries.  Should a greater rights request be submitted
and granted notwithstanding any other provision of this clause, the Requester
agrees that neither it nor any assignee will grant to any person the exclusive
right to use or sell any Subject Invention in the United States unless such
person agrees that any products embodying the Subject Invention or produced
through the use of the Subject Invention will be manufactured substantially in
the United States.  However, in individual
cases, the requirement for such an agreement may be waived by DOE upon a
showing by the Requester or its assignee that reasonable but unsuccessful
efforts have been made to grant licenses on similar terms to potential
licensees that would be likely to manufacture substantially in the United
States or that under the circumstances domestic manufacture is not commercially
feasible.

 

D.                                    Minimum Rights to the Requester

 

The
Requester reserves a revocable, nonexclusive, paid-up license in each patent
application filed in any country on a Subject Invention and any resulting
patent in which the Government acquires title. 
Revocation shall be in accordance with the procedure of
paragraph (c)(2) and (3) of the clause in 41 CFR 9-9.107-5(a).
The Requester also has the right to request foreign rights in accordance with
the procedures of paragraph (c)(4) of the clause in 41 CFR
9-9.107-5(a).

 

E.             Employee and Subcontractor Agreements

 

Unless
otherwise authorized in writing by the Contracting Officer, the Requester
shall:

 

(1)           Obtain patent agreements to effectuate the provisions of the Patent
Rights clause from all persons in its employ who perform any part of the work
under this agreement except nontechnical personnel, such as clerical employees
and manual laborers.

 

(2)           Include the Patent Rights clause at 48CFR952.227-71 entitled “Patent
Rights - Small Business Firms or Nonprofit Organizations - April 1987”,
suitably modified to identify the parties, in all subcontracts, regardless of
tier, for experimental, developmental or research work to be performed in the
United States by a small business firm or a. nonprofit organization.  (Text of this clause is available from DOE
Patent Counsel or Contracting Officer.) 
In all other subcontracts, regardless of tier, for experimental,
developmental, demonstration, or research work, the Requester will

 

non-waiver 1/95

 

4

 

* Confidential Treatment Requested by Celera
Corporation*

 

include
the Patent Rights clause of 41 CFR 9-9.107-5(a) or 41 CFR 99.107-6 as
appropriate and as revised by 48CFR927.300(a), modified to identify the
parties.

 

(3)           Notify promptly the Contracting Officer in writing upon the award of
any subcontract under this agreement containing a Patent Rights clause by
identifying the subcontractor, the work to be performed under the subcontract,
and the dates of award, and estimated completion.  Upon the request of the Contracting Officer,
the Requester shall furnish a copy of the subcontract to such Contracting
Officer.

 

F.           Atomic Energy

 

(1)           No claim for pecuniary award or compensation under the provisions of
the Atomic Energy Act of 1954, as amended, shall be asserted by the Requester
or its employees with respect to any invention or discovery made or conceived
in the course of or under this agreement.

 

(2)           Except as otherwise authorized in writing by the Contracting Officer,
the Requester will obtain patent agreements to effectuate the provisions of
paragraph (E)(1) of this clause from all persons who performs any
part of the work under this agreement, except nontechnical personnel, such as
clerical employees and manual laborers.

 

G.            Publication

 

It
is recognized that during the course of the work under this agreement the
Requester or its employees may from time to time desire to release or publish
information regarding scientific or technical developments conceived or fast
actually reduced to practice by Requester or its employees in the course of or
under this agreement.  In order that
public disclosure of such information will not adversely affect the patent
interests of DOE, the University or the Requester, patent approval for release
or publication shall be secured from Patent Counsel and University prior to any
such release or publication by the Requester and shall be secured from Patent
Counsel and the Requester prior to any such release or publication by LBL.  Such approval shall not be unreasonably
withheld or denied beyond 30 days.

 

H.            Limitation of Rights

 

Nothing
contained in this patent rights clause shall be deemed to give the Government
any rights with respect to any invention other than a Subject Invention except
as set  forth in the Facilities
License of paragraph I.

 

non-waiver 1/95

 

5

 

* Confidential Treatment Requested by Celera
Corporation*

 

I.              Facilities License

 

In
addition to the rights of the parties with respect to inventions or discoveries
conceived or first actually reduced to practice in the course of or under this
contract, the Requester agrees to and does hereby grant to the Government an
irrevocable, nonexclusive paid-up license in and to any inventions or
discoveries regardless of when conceived or actually reduced to practice or
acquired by the Requester, which at any time through completion of this
contract are owned or controlled by the Requester and are incorporated in the
facility as a result of this agreement to such an extent that the facility is
not restored to the condition existing prior to the agreement (1) to
practice or to have practiced by or for the Government at the facility, and (2) to
transfer such license with the transfer of that facility.  The acceptance or exercise by the Government
of the aforesaid rights and license shall not prevent the Government at anytime
from contesting the enforceability, validity or scope of, or title to, any
rights or patents herein licensed.

 

VI.           PATENT AND COPYRIGHT INDEMNITY-LIMITED

 

The Requester shall indemnify the Government
and the University and their officers, agents, and employees against liability,
including costs, for infringement of any United States patent or copyright
arising out of any acts required or directed by the Requester to be performed
under the agreement to the extent such acts are not normally performed at the
facility.  Further, the foregoing
indemnity shall not apply unless the Requester shall have been informed in a
reasonable time by the University or Government of the suit or action alleging
such infringement, and such indemnity shall not apply to a claimed infringement
which is settled without the consent of the Requester unless required by a
court of competent jurisdiction.

 

VII.          RIGHTS IN TECHNICAL DATA

 

A.            Definitions

 

(1)                                  “Technical Data” means recorded information
regardless of form or characteristics, of a scientific or technical
nature.  It may, for example, document
research, experimental, developmental, demonstration, or engineering work, or
be usable or used to define a design or process, or to procure, produce,
support, maintain, or operate material. 
The data may be graphic or pictorial delineations in media such as
drawings or photographs, text in specifications or related performance or
design type documents or computer software (including computer programs,
computer software data bases, and computer software documentation).  Examples of technical data include research
and engineering data, engineering drawings, and associated lists,
specifications, standards, process sheets, manuals, technical reports, catalog
item identification, and related information. 
Technical data as  used
herein does not include financial reports, cost analyses, and other information
incidental to agreement administration.

 

non-waiver 1/95

 

6

 

* Confidential Treatment Requested by Celera
Corporation*

 

(2)                                  “Proprietary Data” means technical data which
embody trade secrets developed at private expense outside of this agreement,
such as design procedures or techniques, chemical composition of materials, or
manufacturing methods, processes, or treatments, including minor modifications
thereof, provided that such data:

 

(a)                                  Are not generally known or available by the
owner to others without obligation concerning their confidentially.

 

(b)                                 Have not been made available by the owner to
others without obligation concerning their confidentially, and

 

(c)                                  Are not already available to the Government
without obligation concerning their confidentially.

 

(3)                                  “Contract Data” means technical data first
produced in the performance of the agreement, technical data which are
specified to be delivered in the agreement, technical data that may be called
for under the “Additional Technical Data Requirements” clause of the agreement,
if any, or technical data actually delivered in connection with the agreement.

 

(4)                                  “Unlimited Rights” means rights to use, duplicate,
or disclose technical data, in whole or in part, in any manner and for any
purpose whatsoever, and to permit others to do so.

 

B.            Allocation of Rights

 

(1)                                  The Government shall have:

 

(a)                                  Unlimited Rights in technical data first
produced or specifically used in the performance of this agreement;

 

(b)                                 The right of the Contracting Officer or his
representative to inspect at all reasonable times up to three (3) years
after final payment under this agreement all technical data first produced or
specifically used in the agreement (for which inspection the Requester shall
afford proper facilities to DOE);

 

(c)                                  The right to have any technical data first
produced or specifically used in the performance of this agreement delivered to
the Government as the  Contracting
Officer may from time to time direct during the progress of the work or in any
event as the Contracting Officer shall direct upon completion or termination of
this agreement.

 

(2)                                  The Requester shall have:

 

The
right to use for its private purpose, subject to patent, security or other
provisions of this agreement, technical data it first produces in the
performance of this agreement provided the data requirements of this agreement
have been met as of the date of the private use of such data.  The Requester agrees that to the extent it
receives or is given access to proprietary data or other technical, business or
financial data in the form of recorded information from DOE or a DOE contractor
or subcontractor, the Requester shall treat such data in accordance with any
restrictive legend contained thereon, unless use is specifically authorized by
prior written approval of the Contracting Officer.

 

C.                                     Copyrighted Material

 

(1)                                  The Requester agrees to, and does hereby
grant to the Government, and to its officers, agents, servants and employees
acting within the scope of their duties;

 

(a)    A royalty-free, nonexclusive, irrevocable
license to reproduce, translate, publish, use, and dispose of and to authorize
others to do so, all copyrightable material first produced or composed in the
performance of this agreement by the Requester or its employees or any
individual or concern specifically employed or assigned to originate and
prepare such material; and

 

(b)   A license as aforesaid under any and all
copyrighted or copyrightable works not first produced or composed by the
Requester in the performance of this agreement but which are incorporated in
the material furnished under the agreement, provided that such license shall be
only to the extent the Requester now has, or prior to completion or final
settlement of the agreement may acquire, the right to grant such license
without becoming liable to pay compensation to others solely because of such
agreement.

 

(2)                                  The Requester agrees that it will not
knowingly include any material copyrighted by others in any written or
copyrightable material furnished or delivered under this agreement without a
license as provided for in subparagraph (1)(b) hereof, or without the
consent of the copyright owner, unless it obtains specific written approval of
the Contracting Officer for the inclusion of such copyrighted material.

 

non-waiver 1/95

 

7

 

* Confidential Treatment Requested by Celera
Corporation*

 

VIII.                         NOTICE AND ASSISTANCE REGARDING PATENT AND
COPYRIGHT INFRINGEMENT

 

A.                                   The Requester shall report to the Government,
promptly and in reasonable written detail, each notice or claim of patent or
copyright infringement based on the performance of this agreement of which the
Requester has knowledge.

 

B.                                     In the event of any claim or suit against the
Government on account of any alleged patent or copyright infringement arising
out of the performance of this agreement or out of the use of any supplies
furnished or work or services performed hereunder, the Requester shall furnish
to the Government when requested by the Government, all evidence and
information in possession of the Requester pertaining to such suit or claim. Such
evidence and information shall be furnished at the expense of the Government
except where the Requester has agreed to indemnify the Government

 

IX.                                WARRANTIES

 

Neither the Government, DOE, the University,
nor persons acting on their behalf will be responsible for any injury to or
death of persons or other living things or damage to or destruction of property
or for any other loss, damage or injury of any kind whatsoever resulting from
the performance of services or furnishings of materials hereunder.

 

Neither the Government, DOE, the University,
nor persons acting on their behalf makes any warranty, express or implied (1) with
respect to the accuracy, completeness or usefulness of any information
furnished hereunder, (2) that the use of any such information may not
infringe privately owned rights, (3) that the services, materials, or
information furnished hereunder will not result in injury or damage when used
for any purpose, and (4) that the services, materials or information
furnished hereunder will accomplish the intended results or are safe for any
purpose including the intended purpose.

 

Neither the Government, DOE, the University,
nor persons acting on their behalf will be responsible, irrespective of cause,
for failure to perform the services or furnish the materials or information
hereunder.

 

X.                                    INDEMNITY

 

The Requester agrees to indemnify and save
harmless the Government, DOE, the University, and persons acting on their
behalf from (1) all liability, including costs and expense incurred,
resulting from the Requester use or disclosure of any information in whatever
form, furnished hereunder, and (2) all liability to any person including
the Requester for injury to or death of persons or other living things or
injury to or destruction of property arising out of performance by the
Government, DOE, the University, or persons acting on their behalf, and not
directly resulting from the fault or negligence of the Government, DOE, the
University, or persons acting on their behalf, or

non-waiver 1/95

 

8

 

* Confidential Treatment Requested by Celera
Corporation*

 

arising out of the use of the services
performed, material supplied, or information given hereunder by any person
including the Requester.

 

The
foregoing provisions shall have no application to public liability for nuclear
incident as defined and provided for in the Atomic Energy Act of 1954, as
amended.

 

XI.                                ENVIRONMENTAL PROTECTION, HEALTH AND SAFETY

 

Full
responsibility for the conduct and safety of Requester personnel at the
University’s sites during the performance of the work shall be and remain with
Requester. Requester shall maintain Worker’s Compensation Insurance at levels
sufficient to cover its obligations under this Agreement.  While at the University’s sites, the
Requester’s personnel are responsible for and shall take all reasonable
precautions in the performance of their work under this Agreement to protect
the environment and the safety and health of employees and members of the
public and shall comply with all applicable environmental health, and safety
regulations and requirements of LBL.  In
accordance with Chapter 23, “Environmental Health and Safety Training”, of
LBL’s Publication 3000, “Health and Safety Manual”, environmental health and
safety orientation and training shall be obtained by Requester’s personnel at
the earliest possible time upon arrival at the University’s site (within 30
days) and in all cases before they work unsupervised or are exposed to any
special hazards.

 

XII.                            INCORPORATION BY REFERENCE

 

The
following standard Government clauses are incorporated herein by reference of
appropriate sections of the Federal Acquisition Regulations and apply as if set
forth herein in full:

 

	
   

  	
  Convict Labor

  	
  FAR52.222-3 (APR 1984)

  
	
   

  	
  Covenant Against
  Contingent Fees

  	
  FAR52.203-5 (APR 1984)

  
	
   

  	
  Equal Opportunity

  	
  FAR52.222-26 (APR 1984)

  
	
   

  	
  Officials Not to Benefit

  	
  FAR52.203-1 (APR 1984)

  
	
   

  	
  Contract Work Hours and
  Safety Standards

  	
   

  
	
   

  	
  Act
  - Overtime Compensation -

  	
  FAR52.222-4 (MAR 1986)

  

 

non-waiver 1/95

 

9

 

* Confidential Treatment Requested by Celera
Corporation*

 

In witness whereof the
parties hereto have executed this agreement.

 

	
   

  	
  THE REGENTS OF THE

  UNIVERSITY OF CALIFORNIA

  AS MANAGEMENT AND OPERATIONS

  CONTRACTOR FOR THE

  LAWRENCE BERKELEY LABORATORY

  
	
   

  	
   

  
	
   

  	
  By:

  	
   

  	
  /s/ Rick M. Inada

  
	
   

  	
  Name:

  	
   

  	
  Rick M. Inada

  
	
   

  	
  Title:

  	
   

  	
  Contracting Officer

  
	
   

  	
  Date:

  	
   

  	
  2/15/96

  
							

 

	
   

  	
  REQUESTER:

  
	
   

  	
   

  
	
   

  	
  By:

  	
   

  	
  /s/ Robert L. Swift

  
	
   

  	
  Name:

  	
   

  	
  Robert L. Swift

  
	
   

  	
  Title:

  	
   

  	
  President/CEO

  
	
   

  	
  Date:

  	
   

  	
  2/12/96

  
							

 

Statement of Work

 

Cholesterol
Research Center

Clinical Laboratory Unit

 

Ronald
M. Krauss.

E.O. Lawrence Berkeley National Laboratory

University of California, Berkeley

 

This
agreement between the Lawrence Berkeley National Laboratory (LBNL) and Berkeley
HeartLab, A California Corporation (Berkeley HeartLab) is for lipoprotein
analysis and research and development involving clinically applicable benefits
of these lipoprotein tests.  The long
term goal of this effort is to establish laboratory methodologies that have
clinical significance and bring laboratory methods to clinical application.

 

As
part of this effort, LBNL shall perform one or more of the following tests for
subjects designated by Berkeley HeartLab and provide Berkeley HeartLab with the
data for these subjects:

 

1.             [***]

 

2.             [***]

 

3.             [***]

 

4.             [***]

 

5.             [***]

 

non-waiver 1/95

 

10

 

* Confidential Treatment Requested by Celera
Corporation*

 

6.             [***]

 

7.             [***]

 

8.             Future tests that have been conceived and
reduced to practice outside this agreement may also be applied under this
agreement upon the mutual consent of Dr. Krauss and Berkeley HeartLab
designee.

 

As part of this agreement LBNL shall perform up to [***].

 

In
addition to the standard Test Panels, LBNL may perform additional specialized
tests.  The number of such tests that can
be performed each month will be determined by LBNL based on total costs and
overall test volume.

 

LBNL
will provide administrative and clinic staff support, instructions, supplies
and shipping materials, and make arrangements for the shipping of the test
samples.  LBNL also will determine the
minimum and maximum number of test samples to be shipped in each package.  LBNL will also provide timely submission of
the lab data to the referring physicians, hospitals, or clinics.

 

As
compensation to LBNL for expenses associated with LBNL’s performance of these
responsibilities, Berkeley HeartLab shall reimburse LBNL’s actual cost of
performance anticipated to be at least [***] for the first year for a maximum
of [***] test panels per month pursuant to the attached budget with second and
future year amounts to be adjusted according to the anticipated annual test
volume above [***] tests per year.  Also
included in the budget are anticipated costs associated with travel to meet
with collaborating hospitals and clinics. 
The annual test volume will be reviewed at 6 months and on a quarterly
basis thereafter, with succeeding years limited to a maximum of [***] tests per
year.  Invoices will be issued by LBNL to
Berkeley HeartLab on a monthly basis for actual costs incurred.

 

non-waiver 1/95

 

11

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00141-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00141-of-00352.parquet"}]]